We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alltracel PH. | LSE:AP. | London | Ordinary Share | IE0030515666 | ORD EUR0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.82 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/3/2008 10:58 | 4web - same here | targatarga | |
28/3/2008 10:52 | can't seem to find the proxy promissed in the RNS. Did anyone find it? I would like to give Alimo a proxy to vote against the takeover. I don't hold many shares, but who knows it helps. | 4web | |
28/3/2008 10:48 | And here we have it!!!!! 7.1 Restricted Share Grant Subject to completion of the Acquisition, Tony Richardson will receive 25,000 HemCon shares upon the completion by him of one year's service within the HemCon Group post the Effective Date. In addition, further share allocations will be made to Tony Richardson, depending on the future performance of Alltracel in fiscal years 2008 and 2009. In each year, 37,500 shares will be allocated assuming annual EBITDA targets are achieved, subject to a 10 per cent. performance collar. Should Alltracel fail to achieve its target by between 10 and 20 per cent., the allocation of shares will be reduced to 31,875. In the event that the shortfall is greater than 20 per cent., the allocation will be 22,500 shares. Should Alltracel outperform its EBITDA target by in excess of 10 per cent., an additional 3,750 shares will be allocated. This allocation will increase by 3,750 shares for each 10 per cent. outperformance band, subject to a maximum additional allocation of 15,000 shares in each year. In total therefore, Tony Richardson could potentially be allocated 130,000 shares in HemCon which would amount to approximately 1.1 per cent. of HemCon's current fully diluted share capital. 7.2 HemCon Share Options The Alltracel senior managers specified below will be offered options over HemCon shares upon completion of the Acquisition. These options will vest over 4 years in equal instalments, subject to the relevant individual remaining in employment within the HemCon Group at the date of vesting. The proposed share option grants are detailed in the following table: Employee No. of options over HemCon Shares Tony Richardson 200,000 Camillus Glover 50,000 Nick Hart 30,000 Keith Real 30,000 Stuart Sands 12,500 Davy Corporate Finance, the independent financial adviser to the Independent Directors, has confirmed in writing to the Panel, that in the opinion of the Independent Directors and Davy Corporate Finance, the arrangements are fair and reasonable as respects the interest of the Alltracel Shareholders generally. The Panel has consented to these arrangements. Our good friend Tony Richardson will in the end have 1.1 percent of Hemcon shares. In other words he will own about as much of Hemcon as he owns of Alltracel after producing good (and he knows he will) results for the coming three year. Absurd!! | 4web | |
28/3/2008 10:44 | don't we have any rights on knowing the 2007 figures before anything is done? I would like to know real figures and real prospects for 2008! | 4web | |
28/3/2008 10:41 | So our management is supporting a minus 300% ROI? I am affraid it will be quite difficult to do something about this, but it's absurd that it's possible. What the hell did we invest in if they are happy with this. What can we do? | 4web | |
27/3/2008 18:30 | I can think of a reason why they would sell something that doesn't belong to them, for less than the true value, and it is the same reason that enables hemcon to talk as if it is a done deal, quote - "going ahead with the purchase anyway". scroll down to "Smaller Margin for Error" or just click on "listen now" - about 3 minutes in. | wes1 | |
27/3/2008 16:23 | Looking at the accounts from 1999 to 2006 and then adding the same as 2006 for the undisclosed Financials for 2007 I've calculated on todays exchange rate of eur/gbp of .7847 that it cost us approx £65m to get Alltracel into a condition where the Independent Directors have agreed to sell out our company for £20.8m! The directors are pleased to recommend this deal for our acceptance. I can now see why I'm gutted that there isn't some financial ombudsman that is there to protect shareholders who have loyally held share for six years, from this sort of behavior. Surely they could have forced Hemcon to give good value, or told them to get lost! By now we would probably have had the information the Directors said they would release in the 4th Qtr of 2007 and we'd probably know the 2007 FYE figs. The share price might not be much more than it is today, but we'd know that we are still owners of a company that has every prospect of achieving the sorts of share price we have been holding on patiently for years. The share price could also be a lot higher. What on earth has got hold of the Directors? | alimo | |
25/3/2008 02:02 | Hi 4web I've written it down. Thanks, Alimo | alimo | |
23/3/2008 22:30 | thanks Alimo | 4web | |
20/3/2008 23:08 | I've had a good chat with DANWAITS today, and I'd like to spend the weekend honing a report I'm trying to put together. I need to chat with Alltracel and get information I should be entitled to as a shareholder, and if no reaction comes from them, all grist to the mill. I'll look for a website for the Commercial Court in Ireland to see what procedures I can expect. I need to check what Rule 2.5 of the Takeover Regulations mean. We have to get proof that will stick, but we may get help from the LSE AIM Regulator. If we can get the LSE on our side to help to check for Shorting patterns and have certain questions answered, then there is chance of a glimmer of light, that may get brighter. I think there is a will among the powers that be, to ensure that if a can of worms can be opened, it will be. 4web, I'll check back posts for your email address and I'd like you to check out the wording of something that is near to being presentable - thanks for your offer. | alimo | |
20/3/2008 16:50 | Alimo, what can I do to help you? | 4web | |
20/3/2008 16:37 | I'm still making enquiries in order to present a case to the LSE's AIM regulator, and the Irish Takeover Panel, and to the Alltracel Management, and even to the High Court who will want everything to be squeeky clean. | alimo | |
20/3/2008 10:43 | I think this can surely be possible! | 4web | |
20/3/2008 09:37 | If the shares in HBOS can be sent into a tumble and start a search for the rogues who deliberately caused it, maybe we can ask the LSE's AIM watchdog to take a look at what may be the chances of a similar occurrence happening on ours. Is there any way the AIM can unravel all the possible short trades that occurred between July and 31/12/07? Do these trades have to be included on the daily Buy/Sell information listings coming out of the Stock Exchange? It appears that long trades were interfering with trading every month last year up till about the beginning of September. Now those huge spikes are clear to see on the above Volume Chart, but none of these huge trades appeared on the daily Trades listings. I remember one or two of you making comments at the time about some overhang caused by spreadbetting. Is it possible that shorts by spreadbetting can cause the opposite effect, making our shares underperform just enough to cause the slide down to 9.25p? Has everyone gone on holiday? | alimo | |
17/3/2008 16:13 | 13p unlucky for some Like I said them AP. guys sure have a sense of humour | buywell2 | |
17/3/2008 14:15 | The practice may be, but I can't believe that these particular terms are. I always thought that giving Synpart a minority holding in a privately-held company was a strange thing to do, and strange that they should have accepted it. What's the exit strategy from a holding like that? I am not of course saying that there was anything illegal or immoral in this arrangement, simply that more transparency would make it easier for shareholders to be certain that it was undertaken in their best interests. | supernumerary | |
17/3/2008 12:52 | I would assume they are standard practice in all M&A activity. | viking1066 | |
17/3/2008 12:13 | If such terms exist, it would be interesting to know what they are. I assume that at the time the Synpart deal was signed, the AP directors were clear about the possible shape of a Hemcon deal. I wonder if the Synpart guys were part of the game? | supernumerary | |
17/3/2008 08:32 | Super in any acquisition there is usually a clause within the agreement that says something like "...in the event of an offer to purchase outright the shares of ..... these put options will be converted/expire at a value of.... " One has to assume that the legal parties to the Synpart transaction would have provided for this event, whether they knew in advance, or simply as part of the negotiations. | viking1066 | |
17/3/2008 07:49 | This company is moving into profit as I key I kid you not .... in certain sections they are running at 100% capacity Check out their results ... much progress has been made in the last 6 months to turn this around | buywell2 | |
16/3/2008 17:40 | What we need is ...... | buywell2 | |
16/3/2008 12:58 | Viking - hello again! So you're still a holder? 'The transaction obviously exceeds the value of the put options'. This may be true, but isn't obvious, at least not to me. The option is against Westone shares, not AP shares, so I would have thought it was untouched by the transfer of ownership unless there are specific clauses in the agreement dealing with it? In any case, it's a sign that they're happy either with the deal they've cut with AP/Hemcon management, and/or that Westone is doing at least as well as expected. | supernumerary | |
16/3/2008 10:57 | Super I have not gone away, merely find there is little point anymore. I would suggest that the reason Synpart did not exercise their Put options is because there is no need to do so. The transaction obviously exceeds the value of the put options and they are obviously accepting the price of the Hemcon offer. I do believe that the company is being bought for a song, but if there is no alternative than current management then it is likely that are enough sellers within the institutions to see this going through. | viking1066 | |
15/3/2008 15:35 | Source BioScience (SBS) (formally Medical Solutions) .... results out on monday Read all about it | buywell2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions